Top of this page
Skip navigation, go straight to the content
Categories
-
AGA IBD Parenthood Project provides guidance about pregnancy for women with IBD and their health care team
May 10, 2019
Guest Post by Aimee Frank, Senior Director, Communications, American Gastroenterological Association
A key underserved patient population is women of childbearing age managing chronic conditions. In honor of Mother’s Day, Aimee Frank, Senior Director of Communications at the American Gastroenterological Association (AGA), shares about the IBD Parenthood Project, an effort led by the AGA with support by UCB, to help address the misperceptions women with inflammatory bowel disease and their healthcare providers experience throughout family planning. -
UCB Flies in to DC to Advocate for Innovation
May 02, 2019
Posted by Katelyn Snider, U.S. Communications and Public Affairs
Earlier this week, researchers from across UCB met in Washington, D.C. for the PhRMA Researcher Fly-In. While on Capitol Hill, the UCB team visited the offices of Representatives Doug Collins, Lucy McBath, and David Price, and Senators Johnny Isakson, Richard Burr, and Thom Tillis and walked their staff through the 15-year journey (on average) of how a new medicine is discovered, developed, and delivered at UCB. Each researcher, representing a different part of the drug development process, shared their personal stories about why they’re motivated each day to continue to innovate for patients. -
Advancing Our Green Strategy for the Future
Apr 22, 2019
Posted by Katelyn Snider, U.S. Communications and Public Affairs
We believe our ability to continue to innovate and create value for patients now and in the future will increasingly depend on our positive contributions to environmental sustainability. -
Championing STEM Education for Tomorrow’s Discoveries
Mar 20, 2019
Posted by Katelyn Snider, U.S. Communications and Public Affairs
At UCB, we are inspired by patients and driven by science to deliver what patients value. We are committed to continuously working to advance science and embrace new knowledge — leading to the discovery of new solutions that help patients achieve their goals. -
Welcoming AAD to Washington, D.C.
Feb 28, 2019
Posted by Katelyn Snider, U.S. Corporate Communications and Public Affairs
We’re excited to welcome the 2019 American Academy of Dermatology (AAD) meeting to Washington, D.C. this week. As AAD comes to town, we wanted to offer a few recommendations from our D.C. staff. UCB’s D.C. office focuses on public policy with colleagues in advocacy, policy, public affairs, and regulatory. -
It’s Not Because It’s ‘Rare’ that We Care
Feb 27, 2019
For International Rare Disease Day, our Global Head of the Rozimab Mission, Chris Clark, shares insights about how UCB is leveraging and growing our capabilities to deliver value for specific patient populations new to UCB. Read the full article on LinkedIn. -
Our Innovation Journey: From Patient to Science to Solution
Feb 14, 2019
Posted by Katelyn Snider, U.S. Communications and Public Affairs
With Innovation Day upcoming on February 17, we’re highlighting our approach to innovation, what we call at UCB the “patient-science-solution” model. Everything we do starts and ends with what patients value, but it is a continuous journey. Starting with the patient – we listen to their experiences, what they value, their needs, and keep them at the heart of everything we do. -
Volunteerism Amplifies Our Mission
Feb 06, 2019
Posted by Katelyn Snider, U.S. Communications and Public Affairs
-
How the Big Game in Atlanta Inspires UCB’s Game Plan
Jan 29, 2019
With an estimated 75,000 people coming to Atlanta for the Big Game and over 100 million tuning in to watch it, Duane Barnes, former college football player and UCB’s President, Head of U.S. Operations talks about how having the game in our backyard helps us to reflect on our game plan to deliver wins for patients. Read the full article on LinkedIn. -
Patients Propel Scientific Discovery
Jan 10, 2019
Posted by Katelyn Snider, U.S. Communications and Public Affairs
Patients are at the heart of everything we do, inspiring us, driving our scientific discovery, and focusing us on what patients value. At UCB, we want to help people live their best lives, whatever that means for them. So, every day, we come together to work, laser-focused, on a simple question: How will this create value for people living with severe diseases?